Target intelligence / Profile preview

HLA class I histocompatibility antigen A alpha chain (HLA-A*02) (HLA-A*02)

Target
HLA-A*02
Molecular classification
MHC class I protein, Transmembrane glycoprotein
01

Overview

HLA-A*02 is a specific allele group of the HLA-A gene, which encodes the alpha (α) chain of a human leukocyte antigen (HLA) class I molecule. These molecules are critical components of the immune system, responsible for presenting endogenous peptide antigens to CD8+ cytotoxic T cells. The presented peptide-HLA complex is recognized by T-cell receptors on CD8+ cytotoxic T lymphocytes, triggering immune responses against infected or abnormal cells such as cancerous ones. Typing for HLA-A*02 is routinely performed before organ transplantation to minimize rejection risk. Polymorphisms determine peptide-binding specificity and serotype recognition. It is expressed on virtually all nucleated cells.

Other names
Human Leukocyte Antigen A*02HLA-A A*02 alleleMHC class I antigen A*02
02

Mechanism of action

N/A

03

Biological functions

Antigen presentationImmune responseT cell activation
04

Disease associations

Autoimmune diseasesViral infectionsCancerTransplant rejection
05

Safety considerations

Potential for immune-related adverse events in immunotherapyTransplant rejection if mismatched in organ transplantation
06

Biomarkers

HLA-A*02 status as a predictor of response to certain immunotherapies

Beyond the preview

Go deeper on HLA class I histocompatibility antigen A alpha chain (HLA-A*02) (HLA-A*02).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on HLA class I histocompatibility antigen A alpha chain (HLA-A*02) (HLA-A*02).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call